T2 Biosystems Investors

44 investors on Angel Roster list T2 Biosystems in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series A and the largest groups are based in the United States and Puerto Rico.

Investors are matched on the company name in their portfolio, so companies that share the name T2 Biosystems can appear together.

Investors listed
44
With verified email
57%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 T2 Biosystems investors

The most complete profiles first. Showing 40 of 44.

  • Alex GoldsmithVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Avak KahvejianVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Verified email available

  • David AronoffVerified

    Venture Capital, Angel/Individual, Investor · United States

    SeedPre-SeedCybersecurityCryptocurrencyArtificial Intelligence (AI)Robotics

    Portfolio: CHiL Semiconductor, T2 Biosystems, Minim, Sand 9 and 18 more

    Verified email available

  • Ewen CameronVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Molly GibsonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Nick PlugisVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Sabrina YangVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Sebastian TrousilVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Stephen BerensonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Torben Straight NissenVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Adam WhiteheadVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Alan CraneVerified

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 82 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • Ben WessnerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Brian EnglanderVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Douglas ColeVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Dylan HarmonVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Ignacio MartinezVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 52 more

    Verified email available

  • Jim GilbertVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Scott LiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Todd HolmesVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Eytan Weinstein

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Geoffrey von Maltzahn

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Harry Wilcox

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Contact details available

  • Jacob Rubens

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Nathan Stebbins

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Yiqun Bai, Ph.D.

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedEnterprise SoftwareEnergy

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • John Casey

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Justin Waney

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Luke Duster

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Nate Hukill

    Venture Capital, Private Equity Firm · Puerto Rico

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Noubar Afeyan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Sami Hawwa

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

See all 44 T2 Biosystems investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many T2 Biosystems investors are on Angel Roster?

Angel Roster lists 44 T2 Biosystems investors. 25 of them (57%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (35), Private Equity Firms (20) and Entrepreneurship Programs (9). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do T2 Biosystems investors invest in?

Among those that list a stage, the most common are Series A (14), Seed (2) and Series B (1).

Where are T2 Biosystems investors based?

Most are based in the United States (43) and Puerto Rico (1).

Which companies have T2 Biosystems investors backed?

The most-backed portfolio companies among them are Syros Pharmaceuticals (28), TARIS Biomedical (21), KSQ Therapeutics (21), Ohana Biosciences (20) and Selecta Biosciences (20).

How do I contact T2 Biosystems investors?

Create a free Angel Roster account to search and filter all 44, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.